Macquarie Group’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-850
| Closed | -$35K | – | 1897 |
|
|
2022
Q3 | $35K | Sell |
850
-476
| -36% | -$19.6K | ﹤0.01% | 2031 |
|
|
2022
Q2 | $29K | Sell |
1,326
-657,400
| -100% | -$14.4M | ﹤0.01% | 2196 |
|
|
2022
Q1 | $29.6K | Buy |
658,726
+2,174
| +0.3% | +$98 | 0.02% | 664 |
|
|
2021
Q4 | $28.1M | Sell |
656,552
-12,509
| -2% | -$536K | 0.02% | 669 |
|
|
2021
Q3 | $44.5M | Buy |
669,061
+178,844
| +36% | +$11.9M | 0.04% | 561 |
|
|
2021
Q2 | $35.9M | Buy |
490,217
+489,719
| +98,337% | +$35.9M | 0.03% | 635 |
|
|
2021
Q1 | $34K | Buy |
498
+278
| +126% | +$19K | ﹤0.01% | 2160 |
|
|
2020
Q4 | $15K | Hold |
220
| – | – | ﹤0.01% | 2260 |
|
|
2020
Q3 | $11K | Hold |
220
| – | – | ﹤0.01% | 2267 |
|
|
2020
Q2 | $8K | Buy |
+220
| New | +$8K | ﹤0.01% | 2308 |
|